Vaccine compositions for treating coronavirus infection

Details for Australian Patent Application No. 2005319716 (hide)

Owner ID Biomedical Corporation of Quebec

Inventors Burt, David S.; Hu, Mary Chaohong; Jones, David Hugh; Lowell, George H.; Reddish, Mark A.

Agent Davies Collison Cave

Pub. Number AU-A-2005319716

PCT Pub. Number WO2006/068663

Priority 60/584,704 30.06.04 US

Filing date 30 June 2005

Wipo publication date 29 June 2006

International Classifications

A61K 39/215 (2006.01) Medicinal preparations containing antigens or antibodies - Coronaviridae, e.g. avian infectious bronchitis virus

C07K 14/165 (2006.01) Peptides having more than 20 amino acids

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/068663 Priority application(s): WO2006/068663

14 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005319720-A foil cutter in a dry powder inhaler and a method for cutting open a container

2005319707-Systems and methods for nanowire growth and manufacturing